PDCD1 and non-small cell lung carcinoma: Arasanz et al. [60] monitored peripheral blood mononuclear cells (PBMCs) in NSCLC patients treated with anti-PD-1/PD-L1 antibodies, and peripheral exhausted CD4+ T-cell proliferation was observed in patients with HPD.